The worldwide liquid biopsy industry is seeing substantial increase, driven by developments in cancer detection and targeted treatment. Current assessments position the market size at approximately USD X.X billion in the current year, with expectations indicating a a anticipated annual growth rate of Y.Z% through 2032. Major trends encompass the ri